Full-Time

Vice President Clinical Development

Resilience Care

Resilience Care

201-500 employees

Remote patient monitoring for cancer care

No salary listed

Paris, France + 6 more

More locations: Bordeaux, France | Montpellier, France | Toulouse, France | Anglet, France | Marcy-l'Étoile, France | Marseille, France

In Person

Category
Biology & Biotech (2)
,
Requirements
  • An MD MSc or MD PhD degree
  • Minimum 5 years of clinical development experience on the sponsor side (biotech/pharma)
  • Proven experience managing and scaling clinical development teams
  • Strong understanding of regulatory and inspection requirements
  • Worked in international contexts (EU/US regulatory exposure)
Responsibilities
  • Own the end-to-end clinical development strategy and execution for all Resilience-sponsored studies
  • Provide senior clinical leadership on study design and methodology
  • Provide senior clinical leadership on protocol development and amendments
  • Provide senior clinical leadership on endpoint selection and clinical relevance
  • Provide senior clinical leadership on interpretation of clinical and real-world evidence
  • Ensure alignment and consistency of clinical development approaches across oncology, gastroenterology, and psychiatry
  • Build, lead, and mentor a Clinical Development team composed of Clinical Leads by therapeutic area and Clinical Scientists
  • Define clear roles, responsibilities, and governance across the team
  • Establish scalable ways of working enabling high-quality, timely execution
  • Design and implement standardized clinical development frameworks across business units
  • Harmonize protocol templates and study documentation
  • Harmonize clinical review and governance processes
  • Harmonize decision criteria and escalation pathways
  • Ensure alignment with ICH-GCP, ISO 14155, MDR, and applicable regulatory standards
  • Ensure inspection readiness across all sponsor-led trials
  • Partner with Clinical Operations to drive execution excellence and risk anticipation
  • Ensure quality-by-design principles
  • Act as senior escalation point for clinical development matters
  • Collaborate with Regulatory & Quality, Biostatistics, Medical Affairs, Market Access & Public Affairs, Product and Data teams
  • Ensure clinical development is tightly integrated with company-wide priorities
Desired Qualifications
  • Experience in digital therapeutics or biotechs that have obtained CE/FDA approvals

Resilience Care offers digital health tools for cancer care, combining a remote patient monitoring platform for clinicians with a patient mobile app. The system collects health data remotely to track treatment, side effects, and adherence, while the app helps patients manage daily life and stay connected to their care team. It adapts to any cancer type or treatment and is used across private and public facilities, serving thousands of patients. The goal is to make cancer care more human and coordinated, improving quality of life, adherence, and survival through personalized support and ongoing feedback from patients and caregivers.

Company Size

201-500

Company Stage

Series B

Total Funding

$74.5M

Headquarters

Paris, France

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $25M Series B in 2024 led by Picus Capital and Red River West.
  • Expanded to 200 European centers supporting 35,000 patients with 85% adherence.
  • Appointed Greg Orr, ex-Jasper Health COO, as US General Manager.

What critics are saying

  • Oncora Medical outcompetes with superior AI in US hospitals within 12 months.
  • FDA delays Class IIa clearance stall US rollout in 6 months.
  • HIPAA violations trigger lawsuits exposing 35,000 records in 12 months.

What makes Resilience Care unique

  • Co-founded with Gustave Roussy Institute for oncology expertise.
  • Reduces hospitalizations 38% and toxicities 25% via real-time tracking.
  • First oncology device reimbursed by France's national social security.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Resilience Care who can refer or advise you

Benefits

Flexible Work Hours

Remote Work Options

Health Insurance

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

2%
PR Newswire
Mar 31st, 2026
Resilience Care expands to US with digital oncology platform, appoints Jasper Health veteran Greg Orr as GM

Resilience Care, a digital oncology platform co-founded with Gustave Roussy Institute, has announced its expansion into the United States after establishing operations across 200 European clinical centres supporting over 35,000 patients. The company has appointed Greg Orr, former COO of Jasper Health, as General Manager for the US market. The platform addresses the "between-visit blind spot" in cancer care through real-time symptom tracking and adaptive treatment pathways. In Europe, the system has driven a four- to five-fold increase in nursing capacity whilst maintaining an 85% patient adherence rate after one year of use. Research shows the platform reduces hospitalisations by up to 38% and decreases severe treatment-related toxicities by 25%. The company has assembled a US advisory board including Eddie Martucci of Akili Interactive and former Merck oncology executive Jill DeSimone.

Startup Rise EU
Sep 10th, 2025
Resilience Raises $25M for Healthtech Expansion

Resilience, a Paris-based healthtech startup, has secured €25 million in funding to expand its cancer patient monitoring solutions both domestically and internationally. The company, which operates in over 90 hospitals, aims to increase its presence in Belgium and Germany. The funding round was led by Red River West and Picus Capital, with participation from Cathay Innovation, Singular, and Seaya Ventures. Resilience's remote monitoring platform is the first oncology-related device reimbursed by France's national social security.

Tech.eu
May 23rd, 2024
Resilience raises $25M to expand remote oncology patient monitoring

Resilience raises $25M to expand remote oncology patient monitoring.

FW.MEDIA
May 21st, 2024
RESILIENCE raises $25M for EU expansion

Resilience, a startup specializing in medical telemonitoring for oncology patients, has raised $25 million in a Series B funding round led by Picus Capital and Red River West, with participation from Cathay Innovation, Singular, and Seaya Ventures. This funding aims to support its expansion in Belgium and Germany. Since its inception in February 2021, Resilience has raised €5 million in seed funding and €40 million in Series A. The company serves 10,000 patients across 90 healthcare facilities.

Sifted
May 20th, 2024
Remote cancer patient monitoring platform raises $25m to expand internationally and build out pharma offering

The fresh funding adds to the €45m France-based Resilience had previously raised, since launching in 2021.